USANA Health Sciences, Inc. (NYSE:USNA) Shares Sold by Denali Advisors LLC

Denali Advisors LLC decreased its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 47.6% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 24,700 shares of the company’s stock after selling 22,400 shares during the period. Denali Advisors LLC’s holdings in USANA Health Sciences were worth $1,198,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in USANA Health Sciences by 2.5% during the 3rd quarter. Vanguard Group Inc. now owns 1,567,182 shares of the company’s stock valued at $91,853,000 after purchasing an additional 38,533 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in USANA Health Sciences by 3.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 677,664 shares of the company’s stock worth $36,323,000 after acquiring an additional 21,524 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of USANA Health Sciences by 75.7% in the 4th quarter. Pacer Advisors Inc. now owns 337,371 shares of the company’s stock worth $18,083,000 after buying an additional 145,373 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of USANA Health Sciences by 4.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 222,423 shares of the company’s stock worth $11,922,000 after buying an additional 8,536 shares during the last quarter. Finally, American Century Companies Inc. lifted its position in USANA Health Sciences by 2.3% in the 3rd quarter. American Century Companies Inc. now owns 135,996 shares of the company’s stock valued at $7,971,000 after purchasing an additional 3,028 shares during the last quarter. Hedge funds and other institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Stock Performance

Shares of NYSE:USNA traded up $0.03 during mid-day trading on Wednesday, hitting $44.97. The stock had a trading volume of 20,362 shares, compared to its average volume of 80,407. The company’s 50 day moving average is $46.27 and its 200-day moving average is $47.88. USANA Health Sciences, Inc. has a 12-month low of $41.45 and a 12-month high of $69.60. The company has a market cap of $856.68 million, a PE ratio of 14.00, a P/E/G ratio of 1.36 and a beta of 0.90.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.17. The business had revenue of $227.80 million for the quarter, compared to the consensus estimate of $223.27 million. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. On average, equities research analysts predict that USANA Health Sciences, Inc. will post 2.78 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, DA Davidson cut their price objective on shares of USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 7th.

Insider Activity at USANA Health Sciences

In other USANA Health Sciences news, CFO G Doug Iiekking sold 5,198 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total value of $232,662.48. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, CFO G Doug Iiekking sold 5,198 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total transaction of $232,662.48. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Paul A. Jones sold 2,714 shares of the stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $48.66, for a total transaction of $132,063.24. Following the transaction, the insider now owns 6,266 shares in the company, valued at approximately $304,903.56. The disclosure for this sale can be found here. Over the last three months, insiders have sold 31,591 shares of company stock valued at $1,458,098. Corporate insiders own 0.33% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.